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Dendritic Cell Development and Survival
Require Distinct NF-B Subunits
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The control of DC survival plays an important role in
regulating their T cell priming functions (Josien et al.,
2000; Wong et al., 1997). However, DCs in mice haveSummary
been shown to have a very short life span (Kamath et
al., 2000). Significantly, engagement of CD40 expressedDespite the established role of dendritic cells (DCs) in
on DCs with CD40L expressed on T cells not only stimu-regulating T lymphocyte activation, intracellular mech-
lates maturation and cytokine production but also en-anisms responsible for controlling DC function are
hances DC survival (Caux et al., 1994; Miga et al., 2001).largely undefined. Here, we have studied DCs from
The effect of enhanced DC survival in potentiating T cellmice deficient in the p50, RelA, and cRel subunits of
activation has been best demonstrated by studies ofthe immunomodulatory NF-B transcription factor. Al-
TRANCE, a TNF family member expressed on T cellsthough DC development and function was normal in
that promotes DC survival but not maturation (Josien etmice lacking individual NF-B subunits, development
al., 2000; Wong et al., 1997). These studies have estab-of doubly deficient p50/RelA/ DCs was signifi-
lished a role for CD40L and TRANCE in regulation ofcantly impaired. In contrast, DCs from p50/cRel/
DC survival, although the intracellular survival pathwaysmice developed normally, but CD40L- and TRANCE-
involved have yet to be defined.induced survival and IL-12 production was abolished.
Although the significance of DCs as regulators ofSurprisingly, no significant impairment in MHC and
adaptive immunity is beyond doubt, little is known aboutcostimulatory molecule expression was seen, despite
intracellular mechanisms specifically responsible forsignificantly reduced B site binding activity. These
regulating DC function and survival. Interestingly, manyresults therefore indicate essential, subunit-specific
inducers of DC maturation are also strong activators offunctions for NF-B proteins in regulating DC develop-
NF-B transcription factors (Baldwin, 1996; Ghosh etment, survival, and cytokine production.
al., 1998), suggesting that these factors may play a key
role in DC maturation. The NF-B family of transcriptionIntroduction
factors exist as homodimers or heterodimers of five dis-
tinct proteins (p50, p52, RelA, RelB, and cRel) and playDendritic cells (DCs) are specialized antigen-presenting
an important role in regulating inflammatory and im-cells (APCs) that play an essential role in activation of
mune-response genes (Ghosh et al., 1998). NF-B acti-T lymphocytes (Banchereau et al., 2000; Banchereau
vation occurs by nuclear translocation following induc-and Steinman, 1998). Among APCs, which also include
ible phosphorylation of inhibitory IB proteins by the
macrophages and B cells, only DCs are believed to be
IKK (IB kinase) complex (Karin and Ben-Neriah, 2000).
capable of activating naive T cells. DC function is regu-
All five members of the NF-B family have been
lated by their state of maturation. Originating from both knocked out in mice (Beg et al., 1995; Burkly et al., 1995;
myeloid and lymphoid hematopoietic precursors in the Caamano et al., 1998; Doi et al., 1997; Franzoso et al.,
bone marrow, DCs migrate to the periphery as “imma- 1998; Kontgen et al., 1995; Sha et al., 1995; Weih et al.,
ture” cells (Banchereau et al., 2000; Banchereau and 1995). These studies have identified key roles for NF-
Steinman, 1998; Wu et al., 2001). “Maturation” of DC B proteins in regulation of innate immunity, lymphocyte
can be induced by microbial stimuli, proinflammatory function, and regulation of cell survival (Alcamo et al.,
cytokines, as well as through interaction with CD40L- 2001; Beg et al., 1995; Grumont et al., 1999; Kontgen et
expressing T cells (Banchereau et al., 2000; Banchereau al., 1995; Ouaaz et al., 1999; Sha et al., 1995; Zheng
and Steinman, 1998; Caux et al., 1994; Reis e Sousa, et al., 2001). Studies of RelB/ mice have indicated a
2001). Mature DCs are highly immunogenic due to high specific requirement for this protein in development of
levels of expression of MHC I, II, costimulatory, and CD11cCD8 but not CD11cCD8 DCs (Burkly et
adhesion molecules, including B7-1, B7-2, CD40, and al., 1995; Weih et al., 1995; Wu et al., 1998). However,
ICAM-1. Interaction of DCs with microbial agents, such other than RelB, the function of other NF-B subunits
as lipopolysaccharide (LPS) or CD40L, also induces IL- in DCs is not known.
12 production, a cytokine that regulates Th cell differen- We show here that B site binding complexes in DCs
tiation into Th1 cells (Trinchieri, 1998). Mature DCs pref- consist in large part of p50, RelA, and cRel subunits. To
understand the function of these proteins in DCs, we
have utilized mice deficient in RelA, p50, and cRel (Beg3 Correspondence: aab41@columbia.edu
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et al., 1995; Kontgen et al., 1995; Sha et al., 1995). We we next analyzed DC development in p50/ and cRel/
mice. Similar to RelA/ mice, spleen DCs from bothdemonstrate here that the absence of these individual
subunits does not affect DC survival, maturation, or p50/ and cRel/ also showed the presence of
CD11cCD8and CD11cCD8DCs (Figure 1C). BM-T cell stimulatory function. However, profound defects
in DC development and mature DC function were found derived DCs have high expression of MHC and costimu-
latory molecules and can prime T lymphocytes in vitroin the combined absence of p50RelA or p50cRel,
respectively. Based on the results presented here, we and in vivo (Inaba et al., 1990; Sigal et al., 1999). To
determine whether RelA, p50, or cRel subunits are re-propose a key function of NF-B complexes comprising
of p50, RelA, and cRel in regulation of DC development, quired for expression of T cell stimulatory molecules in
DCs, we derived DC from BM cells of these mice. Adher-survival, and IL-12 production.
ent clusters of immature DCs, and cells with characteris-
tic DC morphology were obtained from wild-type,Results
RelA/, p50/, and cRel/ mice, which expressed
CD11c (data not shown). Importantly, DCs obtained fromComposition of B Site Binding Complexes
different subunit-deficient mice showed normal consti-in Dendritic Cells
tutive and LPS-induced expression of MHC I (H-2K) andTo study NF-B function in dendritic cells (DCs), we
II (I-A), B7-2, and ICAM-1 (data not shown). These resultsfirst determined subunit composition of B site binding
thus indicate that RelA, p50, or cRel subunits are notcomplexes present in bone marrow (BM)-derived DCs.
absolutely essential for expression of MHC and costimu-EMSA analysis was performed with the high-affinity H-2
latory molecules in DCs.B site, in order to detect the maximal number of DNA
Allogeneic stimulation of T cells in a mixed leukocytebinding-competent NF-B complexes in DCs. As shown
reaction (MLR) is one of the defining properties of DCsin Figure 1A, constitutive B site binding activity was
(Inaba et al., 1992). We next determined a possible rolestrongly increased when DCs were treated with micro-
for RelA, p50, and cRel in allogeneic T cell stimulation. Tobial LPS, one of the best known DC maturation-inducing
this end, subunit-deficient BM DCs (“b” MHC haplotype)agents. LPS treatment induced two distinct B site bind-
were  irradiated and incubated with T cells from BALB/ing complexes. Antisera generated against p50 and cRel
c mice (“d” MHC haplotype). In all cases, unstimulatedsignificantly inhibited these complexes, while antisera
and LPS-stimulated DCs induced robust T cell prolifera-generated against RelA had a less significant effect.
tive responses (Figure 1D). These results thus demon-These results thus indicate that NF-B complexes in
strate that the individual absence of RelA, p50, or cReldendritic cells consist of significant levels of p50 and
does not affect DC development, maturation, or T cellcRel but do not preclude presence or involvement of
stimulation.additional NF-B subunits (e.g., p52 and RelB) in LPS-
induced DC responses.
Impaired Dendritic Cell Development in the
Combined Absence of p50 and RelALack of RelA, p50, or cRel Does Not Affect
Development or Maturation The lack of phenotypic defects in RelA, p50, or cRel
DCs may be because of redundancy in function of theseof Dendritic Cells
To determine the possible function of RelA, p50, and NF-B subunits. This possibility was tested by studying
DC development and function in mice lacking more thancRel NF-B subunits in development and function of
DCs, we analyzed DCs from mice specifically lacking one NF-B subunit. Of particular interest was to deter-
mine DC function in mice that are completely deficienteach of these proteins. Since RelA/ mice die at embry-
onic day 15 (Beg et al., 1995), we first generated chimeric in the two major NF-B heterodimers, p50RelA and
p50cRel. The consequence of absence of p50RelAmice following adoptive-transfer of control or RelA/
fetal liver (FL) hematopoietic cells (CD45.2-expressing) was investigated first. Chimeric mice were generated
by adoptive-transfer of fetal liver cells into lethally irradi-into lethally irradiated CD45.1-expressing mice. To de-
termine a role for RelA in DC development, spleen DCs ated CD45.1-expressing mice, as described above for
RelA/ mice. Four to five weeks after transfer, signifi-were obtained from RelA/ FL-transplanted mice. Two
months after transplantation, cells displaying typical cant numbers of CD11c DCs were obtained from
p50/RelA/ FL-transplanted mice. Strikingly, virtuallystellate DC morphology were obtained from spleens of
both control and RelA/ FL-transplanted mice. These no CD11c cells were detected in spleens of mice trans-
planted with p50/RelA/ (Figure 2A). To determinecells were CD45.2-positive, demonstrating their origin
from donor FL hematopoietic cells, and also expressed whether the absence of CD11c cells was indicative
of the absence of DCs or impaired CD11c expression,the DC-specific integrin CD11c (Figure 1B). Previous
studies have shown that the NF-B family member RelB spleen cytospin preparations from control and
p50/RelA/ mice were analyzed. No cells with char-is required for development of CD11cCD8 but not
CD11cCD8 DCs (Wu et al., 1998). In contrast, both acteristic DC morphology were obtained from
p50/RelA/-transplanted mice, while control miceCD11cCD8 and CD11cCD8 DCs were generated
in the absence of RelA (Figure 1B). These results demon- showed many typical DCs (Figure 2B). These results
demonstrate that redundant functions of p50 and RelAstrate that unlike RelB, RelA is not required for develop-
ment of specific DC subsets. include a potentially critical role in DC generation. Signif-
icantly, the virtual absence of DCs indicates a role forConsistent with relatively low reactivity of RelA anti-
sera, total B site binding activity was not significantly p50RelA in generation of both CD11cCD8 and
CD11cCD8 DCs. Monocytes/macrophages and DCsreduced in RelA/ DCs (data not shown). Since EMSA
analyses showed significant levels of both p50 and cRel, originating from myeloid precursors share common he-
Figure 1. Normal DC Development in RelA/, p50/, and cRel/ Mice
(A) NF-B/Rel subunit composition in dendritic cells. Bone marrow-derived dendritic cells were left untreated or stimulated for 30 min and 2
hr with LPS, nuclear extracts prepared and analyzed by EMSA for binding to the H-2K B site (top panel). Nuclear extracts were also
preincubated with anti-RelA (p65), anti-p50, and anti-cRel antibodies prior to incubation with the B site oligonucleotide probe (bottom panel)
(B) Immunostaining of spleen-derived dendritic cells from RelA/ fetal liver-transplanted mice. Spleen DCs were isolated from mice transplanted
with control or RelA/ fetal liver cells. DCs were left unstained (shaded histogram) or stained with FITC-conjugated antibodies against murine
CD45.2 and CD8 and with PE-conjugated antibody against CD11c for analysis by FACS. CD11cCD8 cells are shown in the left rectangle
while CD11cCD8 are shown in the right rectangle, along with respective percentages.
(C) Immunostaining of spleen-derived DCs from cRel- and p50-deficient mice. Spleen DCs were isolated from wild-type, cRel-, and p50-
deficient mice. DCs were left unstained or stained with FITC-conjugated antibody against murine CD8 and with PE-conjugated antibody
against CD11c for analysis by FACS. CD11cCD8 cells are shown in the left rectangle while CD11cCD8 are shown in the right rectangle,
along with respective percentages.
(D) Allogeneic MLR-mediated by RelA/, cRel/, and p50/ bone marrow-derived DCs. CD3 T cells (100,000) from BALB/c mice were
incubated with -irradiated bone marrow dendritic cells (numbers indicated). DCs were left untreated or treated with LPS for 16 hr as indicated.
After 3 days of culture, 3H-thymidine incorporation was determined.
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Figure 2. Impaired Spleen DC Development in p50/RelA/ FL-Transplanted Mice
(A) Immunostaining of spleen DCs from p50/RelA/ and p50/RelA/ mice. Spleen DCs were isolated from mice transplanted with
p50/RelA/ or p50/RelA/ fetal liver cells. DCs were left unstained or stained with FITC-conjugated antibody against murine CD45.2
and with PE-conjugated antibody against CD11c for analysis by FACS. CD11cCD45.2 cells are shown along with respective percentages.
(B) Cytospin-preparation analysis from p50/RelA/ and p50/RelA/ spleens. DCs were isolated from spleens as described above. After
overnight culture, nonadherent cells were collected. Heme 3-stained cytospin preparations are shown.
(C) Immunostaining of p50/RelA/ and p50/RelA/ splenocytes. Low-density splenocytes were prepared from whole spleens. Cells were
left unstained or were stained with FITC-conjugated antibody against murine CD11b (Mac1) and with PE-conjugated antibody against CD45.2
for analysis by FACS. CD11b high macrophages are shown in the rectangles. Because p50/RelA/ splenocytes have a significantly higher
proportion of both CD11b high and CD11b low cells (monocytes), only 25% of total events are shown to clearly distinguish between these
populations. The CD11b population shown indicates cells released by mechanical disruption only, rather than by more efficient enzymatic
treatment.
matopoietic precursors (Wu et al., 2001). We therefore 25% of total events are shown for p50/RelA/ mice)
is likely due to impaired lymphocyte generation (seedetermined whether p50RelA were also required for
macrophage generation. As shown in Figure 2C, CD11b below) rather than an absolute increase in numbers of
macrophages. Macrophages were also detected in cy-high (Mac1) monocyte/macrophages were readily de-
tected in splenocyte preparations of p50/RelA/ FL- tospin preparations and by FACS analysis of peritoneal
cells from p50/RelA/ FL-transplanted mice (data nottransplanted mice. The significantly higher relative per-
centage of p50/RelA/ splenic macrophages (only shown). These results therefore indicate a specific re-
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Figure 3. Analysis of p50/RelA/ Bone
Marrow-Derived DCs
(A) Generation of bone marrow-derived DCs
from fetal liver p50/RelA/- and
p50/RelA/-transplanted mice. Bone mar-
row (BM) cells were used for generation of
DCs. After 3–4 days of culture, clusters of
developing DCs were analyzed by light mi-
croscopy.
(B) Cell death analysis of developing bone
marrow-derived p50/RelA/ and
p50/RelA/ DCs. On day 4 of culture, cells
are harvested and cell death quantified by
measuring cell viability by Trypan blue exclu-
sion. Dead and living cells are shown as a
percentage of total cells.
(C) Cytospin analysis of bone marrow-derived
p50/RelA/ and p50/RelA/ DCs. On
day 6 of culture, DCs were harvested and
cytospin preparations were analyzed.
(D) Immunostaining of bone marrow-derived
p50/RelA/ and p50/RelA/ DCs. On
day 6 of culture, DCs were harvested,
washed, and stained with FITC-conjugated
antibody against CD45.2 and with PE-conju-
gated antibody against CD11c for FACS
analysis.
(E) Analysis of morphology and cell death of
bone marrow-derived macrophages from FL
p50/RelA/- and p50/RelA/-trans-
planted mice. Bone marrow-derived macro-
phages were generated from bone marrow
cells in the presence of recombinant M-CSF.
Cytospin preparations are shown (left panel).
Bone marrow-derived macrophages were
harvested and cell viability determined by
Trypan blue exclusion. Dead and living cells
are shown as a percentage of total cells (right
panel).
quirement for p50RelA in generation of DCs but not p50/RelA/ BM cultures revealed large numbers of
dead cells, although some cells with characteristic DCmacrophages.
To further understand the mechanism responsible for morphology were also present. On day 4, approximately
70% of the cells were dead in p50/RelA/, while onlyimpaired DC generation, BM cells were used for genera-
tion of DCs from p50/RelA/- and p50/RelA/- 20% dead cells were detected in p50/RelA/ cultures
(Figure 3B). As a result of this massive cell death, thetransplanted mice. Within 3 days, clusters of immature
DCs could be detected in cultures of p50/RelA/ BM yield of p50/RelA/ DCs was typically 10% that of
control DCs. However, the small numbers of survivingcells. However, virtually no such clusters were detected
when p50/RelA/ BM cells were cultured under the cells had typical DC morphology (Figure 3C) and CD11c
expression (Figure 3D).same conditions (Figure 3A). Significantly,
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DCs obtained from BM GM-CSF cultures are of my- mice showed normal DC generation and the presence
of both CD11cCD8 and CD11cCD8 DCs (Figureeloid origin and share common myeloid precursors with
5A). Thus, DC development appears specifically depen-monocyte/macrophages (Inaba et al., 1993). The low
dent on p50RelA but not p50cRel.numbers of p50/RelA/ CD11c cells obtained were
As shown in Figure 1A, p50- and cRel-containing com-also CD11b, indicating their myeloid origin (data not
plexes constitute a major proportion of the total B siteshown). We then determined whether impaired in vitro
binding activity in LPS-treated DCs. As shown in FigureDC generation could potentially be due to reduced sur-
5B, compared to BM-derived DCs lacking p50 or cRelvival of p50/RelA/ common myeloid precursors. To
subunits, both untreated and LPS-treated DCs fromthis end, we tested the ability of p50/RelA/ myeloid
p50/cRel/ mice showed dramatically reduced Bprecursors to differentiate into macrophages. In striking
site binding activity. To determine whether normal DCcontrast to DC cultures, p50/RelA/ BM cells readily
maturation in the absence of p50 or cRel may be duedifferentiated into macrophages in the presence of
to redundancy in function of these proteins, we investi-M-CSF (Figure 3E). Significantly, no enhanced suscepti-
gated whether DC maturation induced by LPS was af-bility to cell death was noticed in these cultures (Figure
fected in p50/cRel/ DCs. Interestingly, other than a3E), and similar numbers of macrophages were obtained
small decrease in expression of MHC class II I-A, nofrom control and p50/RelA/ BM cells. These results
significant decrease in basal expression of MHC I, B7-1,indicate that impaired DC generation is not due to re-
B7-2, and ICAM-1 was noticed in p50/cRel/ DCs.duced numbers and/or survival of myeloid precursors in
Upon LPS treatment, expression of both MHC I/II andBM cultures. Together with in vivo studies, these results
costimulatory molecules was strongly and similarly en-provide additional evidence for an essential role for
hanced in wild-type and p50/cRel/ DCs (Figure 5C).p50RelA in DC development. These results also indi-
Furthermore, identical results were obtained followingcate that impaired DC development may be due to high
CD40L treatment of p50/cRel/ DCs (Figure 5C).susceptibility to cell death in the absence of p50RelA.
Thus, significantly reduced B site binding activity in
these DCs does not appear to impair expression of MHCRescue of Lymphocyte but Not DC Generation
and costimulatory molecules. Despite apparently nor-in p50/RelA/ Mice by Wild-Type
mal maturation, allogeneic T cell proliferation inducedHematopoietic Precursors
by p50/cRel/ DCs was reduced compared to wild-Previous studies have shown impaired lymphocyte gen-
type DCs (Figure 5D). On closer examination, we founderation in mice following adoptive transfer of
this was due to significantly reduced survival ofp50/RelA/ FL cells (Horwitz et al., 1997). However,
p50/cRel/ DCs following  irradiation (data notnormal generation of p50RelA-deficient B cells was
shown). However,  irradiation-induced cell death wasshown to occur following culture of hematopoietic pre-
significantly inhibited following LPS treatment (by ancursors in vitro (Horwitz et al., 1997). Significantly, failure
undefined but likely NF-B-independent mechanism),of lymphopoiesis could be rescued by cotransplantation
which also restored p50/cRel/ DC MLR inductionof mice with wild-type (CD45.1) bone marrow cells, indi-
to levels similar to wild-type DCs. Taken together, thesecating that this defect was not cell autonomous. To
results indicate apparently normal maturation and T celldetermine whether p50/RelA/ DC generation could
stimulation in the combined absence of p50cRel sub-be similarly rescued, p50/RelA/ FL cells (CD45.2)
units.were cotransplanted with wild-type CD45.1 bone mar-
Previous studies have indicated a potentially impor-row cells. As shown in Figure 4A, defective
tant role for NF-B proteins in regulating IL-12 expres-
p50/RelA/ B lymphocyte generation was rescued
sion (Yoshimoto et al., 1997). Interaction of DCs with LPS
following coinjection of CD45.1 cells. These results indi-
and CD40L results in potent induction of biosynthesis of
cate normal generation of common lymphoid precursors IL-12 p70, which is generated by dimerization of two
potentially capable of differentiating into lymphocytes independent subunits called p40 and p35 (Trinchieri,
or DCs in these mice. However, generation of 1998). Transcription of both p40 and p35 is induced by
p50/RelA/ CD11c DCs (CD45.2) remained im- LPS and CD40L, likely through interaction of multiple
paired, while CD45.1 CD11c DCs were readily generated transcription factors, including PU.1, IRF-1, and NF-B,
(Figure 4B). These results further underscore a require- with regulatory control elements (Trinchieri, 1998). To
ment for p50RelA in generation of DCs and provide determine whether NF-B proteins are essential for IL-
evidence for a cell-autonomous function for these pro- 12 expression, we utilized DCs from wild-type, p50/,
teins in DC generation. RelA/, cRel/, and p50/cRel/ mice. Northern
analysis of p40 mRNA expression, however, showed no
Significant Reduction in B Site Binding Activity significant reduction in expression in p50/, RelA/,
in p50/cRel/ DCs Does Not Affect and cRel/ DCs treated for 6 hr with LPS, in comparison
Development or Maturation but with control DCs (Figure 6A). In contrast, LPS-induced
Abolishes IL-12 Expression p40 expression was dramatically reduced in
In addition to p50RelA, p50cRel heterodimers con- p50/cRel/ DCs (Figure 6A). Furthermore, CD40L in-
stitute the other main NF-B complex in several cell duction of p40 was also reduced in p50/cRel/ DCs.
types, and as shown in Figure 1A, may comprise the We then tested induction of IL-12 p70 by ELISA using
major NF-B complex in DCs. In order to determine the culture supernatants of control and p50/cRel/ DCs
effect of absence of p50 and cRel subunits, we first treated with LPS. While IL-12 production was significantly
analyzed spleen DC development in p50/cRel/mice. induced in control cells, no detectable IL-12 was produced
following LPS treatment of p50/cRel/ DCs (Figure 6B).Significantly, unlike p50/RelA/ mice, p50/cRel/
NF-B Function in Dendritic Cells
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Figure 4. Analysis of Spleen DC and B Lymphocyte Development in CD45.1-Coinjected Mice
(A) Immunostaining of bone marrow cells from FL p50/RelA/-, p50/RelA/-, and CD45.1-coinjected mice. Bone marrow cells were
collected and stained with PE-conjugated antibody against B220 and with FITC-conjugated antibody against CD45.2 for FACS analysis.
(B) Immunostaining of spleen-collagenase preparations from FL p50/RelA/-, p50/RelA/-, and CD45.1-coinjected mice. Cells were
stained with PE-conjugated antibody against CD11c and with FITC-conjugated antibody against CD45.2 for FACS analysis. CD45.2 cells,
along with percentages, are shown in the right rectangle.
Similarly, CD40L-induced IL-12 production was also abol- sion of CD40 (Figure 7B). In addition, we have also found
that survival of TRANCE-treated p50/cRel/ DCs wasished in p50/cRel/ DCs (Figure 6B). These results thus
demonstrate an essential role for p50cRel in LPS- and also significantly lower than that of control DCs (Figure
7A). CD40L treatment of BM-derived DCs induced highCD40L-induced expression of IL-12.
NF-B levels for up to 36 hr, which were significantly
reduced in p50/cRel/ BM DCs (Figure 7C). Thus,Regulation of Mature DC Survival by CD40L, TRANCE,
and NF-B p50cRel similar to LPS, CD40L-induced B activity also consists
in large part of p50cRel subunits. Induction of antiapo-DC survival can be enhanced following engagement of
CD40 or TRANCE-R. Previous studies have shown that ptotic Bcl-2 family member expression, in particular Bcl-
xL, may be responsible for inhibition of cell death byCD40 and TRANCE-R activate multiple signaling path-
ways, including PI3K/Akt and NF-B (Arron et al., 2001; CD40L and TRANCE (Wong et al., 1997). Furthermore,
ectopic Bcl-xL expression may be sufficient for en-Wong et al., 1999). Based on results showing a poten-
tially important role for p50RelA in developing DC sur- hancement of DC survival (Pirtskhalaishvili et al., 2000).
As shown in Figure 7D, Bcl-xL expression was stronglyvival, we determined whether mature DC survival was
also regulated by NF-B proteins. To this end, we tested induced in wild-type but not in CD40L-treated
p50/cRel/ DCs. We conclude that activation ofthe effect of CD40L treatment on survival of different
NF-B-deficient DCs. Mature BM-derived DCs obtained p50cRel complexes plays an essential role in regulat-
ing survival of mature DCs.from wild-type, p50/, RelA/, cRel/, and
p50/cRel/ mice were incubated in the absence or
presence of CD40L for 5 days. DC survival was substan- Discussion
tially enhanced in wild-type DCs (approximately 6-fold)
and in DCs lacking RelA, p50, and cRel (Figure 7A). Studies carried out over the past several years have
demonstrated the key role played by DCs in regulatingSignificantly, p50/cRel/ DCs were almost com-
pletely impaired in CD40L-induced enhancement of sur- T cell activation. However, signaling pathways involved
in regulating specific aspects of DC function are stillvival (Figure 7A), although both control and
p50/cRel/ DCs were found to have similar expres- poorly understood. To this end, we have carried out a
Immunity
264
Figure 5. Analysis of p50/cRel/ DCs
(A) Immunostaining of spleen-derived DCs from p50/cRel/ and p50/cRel/ mice. Spleen DC were isolated from p50/cRel/ and
p50/cRel/ mice. DCs were left unstained or stained with FITC-conjugated antibody against murine CD8 and with PE-conjugated antibody
against CD11c for analysis by FACS. CD11cCD8 cells are shown in the left rectangle while CD11cCD8 are shown in the right rectangle,
along with respective percentages.
(B) Gel shift analysis of nuclear extracts from p50/, cRel/, and p50/cRel/ bone marrow-derived DCs. Cells were left untreated or
stimulated for 30 min and 2 hr with LPS and nuclear extracts prepared. NF-B activation was analyzed by EMSA.
(C) Immunostaining of bone marrow-derived DCs from p50/cRel/ and p50/cRel/ mice. In the top panel, unstained cells are shown by
the shaded histogram and CD11c cells are shown by the open histogram. In other panels, BM-DCs were left untreated (shaded histogram)
or were stimulated for 24 hr with LPS or CD40L (open histograms). Cells were left unstained or stained with FITC-conjugated antibodies
against H2-K, I-A, and B7.2, and with PE-conjugated antibodies against CD11c, B7.1, and ICAM-1 for FACS analysis.
(D) Allogeneic MLR mediated by cRel/p50/and cRel/p50/ bone marrow-derived DCs. CD3 T cells (100,000) from BALB/c were
incubated with -irradiated bone marrow dendritic cells (500 or 10,000) from wild-type and p50/cRel/ mice. DCs were left untreated or
treated with LPS for 16 hr as indicated. After 3 days of culture, 3H-thymidine incorporation was determined.
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Figure 6. Analysis of IL-12 Expression in DCs
(A) Analysis of IL-12 p40 mRNA expression in bone marrow-derived DCs from RelA-, p50-, cRel-, and p50cRel-deficient mice. Cells were
left untreated or stimulated for 16 hr with LPS or CD40L. RNA was extracted, and IL-12 p40 mRNA expression was analyzed by Northern
blotting. RNA loading was controlled by probing with a specific probe for murine GAPDH.
(B) Analysis of IL-12 p70 production by p50/cRel/ and p50/cRel/ bone marrow-derived DCs. Cells were left untreated or stimulated
for 16 hr with LPS or CD40L. Culture supernatants were collected, and IL-12 p70 production was qualified by ELISA.
comprehensive analysis of the function of immunomod- in DC survival or maturation. In contrast, absence of
ulatory NF-B transcription factors in DCs. Foremost, p50RelA or p50cRel resulted in significantly impaired
our results have identified an essential and nonredun- development and survival/IL-12 production in DCs, re-
dant role for NF-B proteins in regulating development spectively. These results therefore indicate redundant
and survival of DCs. The implications of the findings functions for p50 and RelA in developing DCs and p50
reported here in regulation of DC development and func- and cRel in mature DCs. These results also suggest
tion are discussed below. that p50 and RelA may be the major NF-B subunits in
developing DCs, while p50 and cRel are the predominant
subunits in mature DCs (as shown in Figures 1 and 5).Control of DC Development by NF-B Proteins
Nonetheless, our results do not indicate exclusive rolesMature DCs were found to have high inducible levels of
for RelA, p50, and cRel in developing or mature DCs.nuclear NF-B complexes containing p50, cRel, and to
Indeed, it is possible that these subunits interact anda lesser extent, RelA. However, the individual absence
of any of these proteins resulted in no obvious defects participate with p52 and RelB in controlling DC develop-
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Figure 7. Regulation of DC Survival by CD40L and TRANCE
(A) CD40L- and TRANCE-induced DC survival analysis in RelA-, p50-, cRel-, and p50cRel-deficient mice. BM-DCs were left untreated or
stimulated with recombinant CD40L or TRANCE for 5 days. Cell viability was assayed by Trypan blue exclusion (CD40L) or propidium iodide
staining (TRANCE). CD40L- and TRANCE-induced DC survival is expressed as a fold increase of survival compared to untreated cells.
(B) CD40 cell surface expression on p50/cRel/ and p50/cRel/ bone marrow-derived DCs. Cells were left unstained or stained with
FITC-conjugated antibody against CD40 and analyzed by FACS.
(C) Gel shift analysis of nuclear extracts from p50/cRel/ and p50/cRel/ bone marrow-derived DCs. Cells were left untreated or
stimulated for 36 hr with CD40L and nuclear extracts prepared. NF-B activation was analyzed by EMSA.
(D) Analysis of BcL-xL protein expression in p50/cRel/ and p50/cRel/ bone marrow-derived DCs. Cells were left untreated or stimulated
for 36 hr with recombinant CD40L and cytosolic extracts prepared. BcL-xL expression was analyzed by Western blot. Anti-Cytochrome C
antibody was used to control protein loading.
ment and specific aspects of DC function. Interestingly, complete absence of p50RelA or p50cRel hetero-
dimeric complexes.p50/cRel/ CD4 T cells have significantly impaired
proliferative responses, indicating that these proteins The combined absence of p50RelA dramatically im-
paired DC development, as evidenced by a virtuallymay play a key role in multiple cell types of the immune
system (Zheng et al., 2001). Even though deficiency in complete lack of spleen CD11c DCs (and thus both
CD11cCD8and CD11cCD8) and absence of cellsspecific subunits is expected to affect all complexes
containing these subunits, defects in DCs lacking exhibiting DC morphology. However, in this study we
have not examined Langerhan’s cell generation, whichp50RelA or p50cRel may in large part be due to
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is thought to represent a DC lineage distinct from both that these proteins are essential for regulating CD40L-
and TRANCE-induced survival of mature DCs. Our resultsmyeloid or lymphoid DCs. Significantly, our results have
demonstrated normal generation of p50/RelA/ also indicate that impaired Bcl-xL induction following
CD40L treatment of p50/cRel/ may be responsiblemonocytic/macrophage lineage in vivo. In addition,
studies of cotransplanted mice showed normal for their reduced survival. These findings have thus un-
covered an essential role for NF-B proteins in CD40L-p50/RelA/ lymphopoiesis, while DC generation re-
mained impaired. We believe these results are signifi- and TRANCE-induced survival pathways in DCs.
cant because they demonstrate that p50RelA are not
essential for generation of myeloid or lymphocyte pre- DC Maturation in NF-B-Deficient DCs
cursors capable of differentiating into macrophages, DC maturation accompanies distinct changes in mor-
lymphocytes, or DCs. Instead, our results indicate that phology and in expression of immunostimulatory mole-
p50RelA are specifically required during differentiation cules. Promoter studies have shown an important role
of these precursors into myeloid- or lymphoid- for NF-B sites in regulating expression of MHC and
derived DCs. costimulatory molecules, in particular H-2K, B7-1, B7-2,
To provide insights into potential mechanisms re- and ICAM-1 (Baeuerle and Henkel, 1994; Ghosh et al.,
sponsible for impaired DC generation, we derived my- 1998). Our studies in fibroblasts have also identified
eloid DCs from BM of p50/RelA/ FL-transplanted essential roles for NF-B proteins in regulating cell sur-
mice. In comparison to control cultures, the yield of face expression of H-2K and ICAM-1 (our unpublished
p50/RelA/ DCs was considerably reduced. Our re- data). In DCs, high NF-B levels have been detected
sults indicate that the low yields are likely the conse- (Granelli-Piperno et al., 1995), suggesting their possible
quence of cell death and may indicate: (1) high suscepti- involvement in MHC and costimulatory molecule ex-
bility of common myeloid precursors of DCs and pression. Finally, treatment of DCs with the antioxidant
macrophages to cell death; (2) inability of p50/RelA/ NAC and the protease inhibitor TPCK, which inhibit NF-
myeloid precursors to differentiate into DCs and which B activation but also have additional pleiotropic ef-
therefore undergo passive cell death in culture; and (3) fects, has been used as evidence for a role of NF-B in
cell death of p50/RelA/ precursors during differenti- regulating T cell stimulatory molecule expression in DCs
ation into DCs. The first possibility appears unlikely (Rescigno et al., 1998; Verhasselt et al., 1999).
since normal numbers of macrophages could be gener- However, we have found that DCs lacking p50, RelA,
ated from p50/RelA/ myeloid precursors. Instead, or cRel exhibited no obvious defects in expression of
the second and third possibilities are more consistent MHC I, II, or the costimulatory molecules B7-1, B7-2, and
with our data. Although these two possibilities are diffi- ICAM-1. Most surprising were results on p50/cRel/
cult to discriminate at present, the generation of some DCs, which showed dramatically reduced B site bind-
DCs suggests that p50RelA are not absolutely required ing activity but apparently normal LPS- and CD40L-
for commitment to the DC lineage and thus are more induced upregulation of MHC and costimulatory mole-
likely required for survival of developing DCs. A key cules. It is nonetheless possible that additional B site
unresolved question is the mechanism of activation of binding activity comprising of p52 and/or RelB, which
p50RelA complexes; e.g., are they specifically acti- may not be readily detectable by EMSA, can function
vated by exogenous ligands acting on developing DCs in DC maturation. In addition to LPS, DC maturation can
or by cell-intrinsic mechanisms that are induced during also be induced by several additional microbial agents
DC development? Our results also indicate that absence including PGN, CpG, and dsRNA (Banchereau et al.,
of myeloid-related DCs in RelB/ mice may reflect a 2000). It will therefore be important to determine whether
specific requirement for RelB in survival of the myeloid maturation induced by these agents is dependent or
DC subset (Wu et al., 1998). Studies of mice deficient in independent of NF-B proteins.
the transcription factors Ikaros and PU.1 have identified We have, however, found that NF-B proteins are es-
defects in development of multiple lineages (Cortes et sential for LPS- and CD40L-induced IL-12 expression.
al., 1999; McKercher et al., 1996), including DCs (Ander- Thus, p50/cRel/ DCs were found completely im-
son et al., 1998; Wu et al., 1997). In contrast, our results paired in inducing IL-12 expression, while p50/,
and studies of RelB mice indicate a much more specific cRel/, or RelA/ showed normal expression. In con-
function for NF-B in DC development. Nonetheless, the trast to an essential and highly specific role of cRel in
precise roles played by Ikaros, PU.1, and NF-B proteins regulating p40 IL-12 expression in macrophages (San-
in DC development remain to be determined. jabi et al., 2000), our results show that p40 expression
is dependent on redundant functions of p50 and cRel
in DCs. Interestingly, cRel was recently shown to beControl of DC Survival by NF-B Proteins
The high susceptibility of DCs to apoptosis has been essential for IL-12 p35 expression in CD8 (Grumont
et al., 2001) but dispensable for IL-12 p40 expressionwell documented by in vitro and in vivo studies. How-
ever, during an antigen-specific immune response, DCs (consistent with the findings reported here). These re-
sults thus indicate further specificity of NF-B subunitthat are able to interact with T cells expressing CD40L
and TRANCE are protected from cell death. Enhance- function in different DC subsets. Together with previous
studies on IRF-1/ mice (Lohoff et al., 1997; Taki et al.,ment of DC longevity in this manner can profoundly
impact T cell priming, but mechanisms involved in this 1997), our findings demonstrate that NF-B and IRF-1
factors may play the most essential roles in regulatingprocess are poorly understood. In contrast to the ab-
sence of p50RelA, we have found that DCs are gener- IL-12 expression. Taken together, our results indicate
that NF-B proteins appear essential for the final phaseated normally in the absence of p50cRel subunits but
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xL or anti-Cytochrome C Abs (Santa Crutz Biotechnology). Nuclearof DC “activation” triggered by interaction with T cell-
and cytoplasmic extract preparation and EMSA were carried outexpressed CD40L and TRANCE molecules, and re-
using a previously described procedure (Zheng et al., 2001). In somesulting in enhancement of DC survival and IL-12 pro-
experiments, nuclear proteins were preincubated with anti-RelA
duction. (p65), anti-p50, and anti-cRel Abs (Santa Crutz Biotechnology) for
In conclusion, our results have demonstrated highly 15 min prior to incubation with the B site oligonucleotide probe.
specific functions for NF-B transcription factors in DCs.
Our results show that DC development and survival/ Allogeneic MLR
CD3 T cells from BALB/c mice (haplotype “d”) were coculturedIL-12 expression are regulated by NF-B proteins in a
with -irradiated (3000 rads) bone marrow or spleen dendritic cellshighly subunit-specific manner. The key role played by
from C57BL/6-L129 NF-B-deficient mice (haplotype “b”) in RPMIDCs in regulating T cell activation and tolerance has
(GIBCO-BRL) medium with 2-ME supplemented with 10% fetal bo-
generated considerable interest in the therapeutic po- vine serum and antibiotics. After 3 days, the cultures were pulsed
tential of DCs. The apparent independence of DC matu- with 1 Ci/well (3 H)-thymidine for the last 16 hr, harvested, and
ration and survival may thus allow development of thera- counted using a Micro-Betaplate reader. All assays were performed
in triplicate, and standard deviations are shown in the figures.peutic strategies that can individually target these
pathways in DCs.
DC Survival Assays
On day 6, BM-DC clusters were dislodged, washed, and transferredExperimental Procedures
to new culture dishes and incubated overnight. On day 7, DCs were
left untreated or treated with 1 g/ml of purified recombinantMice
TRANCE or 1/100 dilutions of recombinant CD40L-containing bacu-C57BL/6 CD45.2(Ly5.1), C57BL/6 CD45.1 (Ly5.2) congenic mice
lovirus supernatant (Wong et al., 1997). DC survival was quantifiedwere obtained from NCI (Bethesda, MD). BALB/c mice were ob-
by measuring cell viability (Trypan blue exclusion or PI staining) astained from Jackson Laboratories, Bar Harbor, ME. The cRel/
shown by fold increase in cell survival compared to untreated DCs.(Kontgen et al., 1995), p50/ (Sha et al., 1995), and RelA/ (Beg
et al., 1995) mice were interbred to generate p50/cRel/ and
p50/RelA/ mice. All experiments were performed in accordance Acknowledgments
with institutional guidelines.
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